INNOVATE Corp. (VATE) | The Buildout — AI Infrastructure
The Verdict
INNOVATE Corp. is a diversified holding company. Its Infrastructure segment, DBM Global, fabricates and erects structural steel — the frame of data centers, chipmaker facilities and advanced-manufacturing plants — through Schuff Steel, Banker Steel and GrayWolf Industrial. Life Sciences holds R2 Technologies' Glacial skin devices, MediBeacon's kidney-function measurement system and Genovel's knee replacements; Spectrum owns and operates broadcast television stations. Management describes the opportunities as concentrated around AI infrastructure, energy systems, advanced manufacturing and digital connectivity, and says DBM sees significant opportunities in technology markets, specifically data centers and chipmakers. The company has agreed to sell DBM Global, closed a refinancing of its broadcasting business and agreed a partial sale of that business, so the portfolio described here is in transition.
| Market Cap | — |
| Revenue (TTM) | $1.5B |
| Revenue Growth | +52.4% |
| EBITDA Margin (TTM) | 6.2% |
| Net Debt | $595M |
| Earnings Beats | 6 of 6 |
| P/E (TTM) | — |
| EV/EBITDA (TTM) | — |
What We Like
- Infrastructure revenue was $357.9 million in Q1 2026, up 35.1% from $264.9 million, with segment adjusted EBITDA of $23.0 million versus $16.7 million.
- DBM Global's adjusted backlog was $1.8 billion at March 31, 2026, held flat while revenue grew; Infrastructure remaining performance obligations were $1,585.6 million, of which $1,141.1 million is due within one year.
- Management's Q1 2026 language cites "AI infrastructure, energy systems, advanced manufacturing and digital connectivity," and says DBM sees "significant opportunities in the technology markets, specifically data centers, chipmakers and other specialty technology projects."
- Infrastructure gross margin compression narrowed to about 140 basis points in Q1 2026 from about 510 basis points in Q3 2025.
- The company has a track record of beating analyst estimates.
What We’re Watching
- The DBM Global sale to IES Holdings, announced August 10, 2026 at approximately $650 million in cash and IES stock. Closing timing, the cash/stock split and the use of proceeds are not disclosed.
- Two unnamed Infrastructure customers were 31.0% and 13.9% of Q1 2026 revenue, each below 10% a year earlier, against the FY2025 disclosure of 22.1% for the two largest DBMG customers.
- Life Sciences revenue fell 48.4% to $1.6 million while R2 backlog grew to about 160 systems, nearly $2.0 million in revenue; R2 is seeking external capital to continue progress through 2026.
- The 10-Q carries a going concern qualification; total principal debt was $699.0 million at March 31, 2026, up $11.8 million on PIK interest.
The thesis is in transition rather than simply intact or weakening. The Infrastructure business — the source of nearly all consolidated revenue and adjusted EBITDA — is growing and holding a $1.8 billion adjusted backlog, but it is the segment under agreement to be sold. That sale, the June 1 Broadcasting refinancing and partial sale, and R2's search for outside capital all read as responses to a parent balance sheet with $699.0 million of principal debt and $2.5 million of stand-alone corporate cash. The open question is what the remaining company earns after DBM Global leaves, and whether the sale closes on the announced terms.
Earnings Beat
INNOVATE reported Q2 FY2026 revenue of $421.6 million, gross margin of 18.9% and EBITDA of $38.0 million, a 9.0% margin. Net income was $10.7 million, versus a net loss of $19.8 million in the year-ago quarter.
| Metric | Q2 FY2026 | Q1 FY2026 | Q2 FY2025 | YoY |
|---|---|---|---|---|
| Revenue | $422M | $365M | $242M | +74.2% |
| Gross margin | 18.9% | 13.5% | 18.8% | +10bps |
| EBITDA | $38M | $18M | $12M | +208.9% |
| EPS | $0.76 | $-1.26 | $-1.51 | −150.6% |
| DBM Global adjusted backlog | $1.8B (Mar 31, 2026) | $1.8B (Dec 31, 2025) | n/a | — |
We see a lot of capital is moving into physical infrastructure for computing in the United States. We are specifically seeing opportunities in technology-related construction markets and are concentrated around AI infrastructure, energy systems, advanced manufacturing and digital connectivity.— Paul Voigt, Interim CEO, May 14, 2026
Management tone: On the Q1 2026 call, held May 14, 2026, management was optimistic on Infrastructure demand but less specific on the DBM Global sale process than on the Q3 2025 call. The Q3 2025 call said the company had engaged Jefferies & Company and initiated a sales process for DBM; the Q1 2026 call shifted to "working with our lenders on strategic alternatives as we focus on fixing our capital structure" and did not update the prior R2 or MediBeacon China items it had flagged. The CEO closed with "Hopefully, we'll come back to you very soon with some positive news," which was followed by the June 1 Broadcasting refinancing and partial sale and the August 10 DBM Global sale agreement. Neither the Q1 2026 nor the Q3 2025 call had analyst questions; the Q1 2026 operator said, "We have reached the end of the question-and-answer session."
Management Guidance
No quantitative guidance was issued. The Q1 2026 call carried no quantitative guidance for the consolidated business or for Infrastructure. Management's forward statements were qualitative: it cited "early success in building backlog for 2027," and said discussions were underway for Spectrum market launches in the second half of 2026.
Trajectory
Revenue is lumpy quarter to quarter: $242.0 million in Q2 FY2025, $347.1 million in Q3 FY2025, $382.7 million in Q4 FY2025, $364.8 million in Q1 FY2026 and $421.6 million in Q2 FY2026. EBITDA moved from $12.3 million in Q2 FY2025 to $38.0 million in Q2 FY2026, a 9.0% margin. Nearly all of it comes from Infrastructure — $357.9 million of Q1 FY2026 revenue and $23.0 million of segment adjusted EBITDA, at a 14.2% gross margin, down about 140 basis points y/y but a far narrower decline than the roughly 510 basis points recorded in Q3 FY2025. Adjusted backlog rose from about $1.1 billion at the end of 2024 to $1.8 billion at March 31, 2026, holding flat while Q1 revenue grew 35.1%. The CFO tied the Q1 Infrastructure increase to the timing and size of large commercial structural steel projects, partly offset by lower industrial maintenance and repair work.
The Model
The model projects FY+1 revenue of $1,630.6 million and EBITDA of $130 million, an 8.0% margin, then FY+2 revenue of $1,710.0 million and EBITDA of $154 million, a 9.0% margin. The near term is anchored on DBM Global's backlog — $1.8 billion adjusted at March 31, 2026, with $1,141.1 million of Infrastructure remaining performance obligations due within one year. The FY+2 case depends on what the consolidated company contains, against a backdrop of the announced DBM Global sale: the FY+2 revenue spread across the five independent runs is 108%, far wider than the 11% FY+1 spread.
| Metric | FY2025 | Next FY (E) | Following FY (E) |
|---|---|---|---|
| Revenue | $1.2B | $1.6B | $1.7B |
| YoY Growth | — | +30.9% | +4.9% |
| EBITDA | $62M | $130M | $154M |
| EBITDA Margin | 5.0% | 8.0% | 9.0% |
Projections are the median of 5 independent model runs. The model’s revenue sits 18.0% below analyst consensus.
No quantitative guidance was issued. The Q1 2026 call carried no quantitative guidance for the consolidated business or for Infrastructure. Management's forward statements were qualitative: it cited "early success in building backlog for 2027," and said discussions were underway for Spectrum market launches in the second half of 2026.
What Could Go Right — and Wrong
- DBM Global's $1.8 billion adjusted backlog and $1,141.1 million of within-one-year remaining performance obligations convert into continued high-revenue quarters.
- Infrastructure gross margin compression keeps narrowing from about 140 basis points in Q1 2026 toward flat year-over-year.
- The DBM Global sale to IES Holdings closes at the announced approximately $650 million, bringing cash and stock to the parent.
- R2's roughly 160-system backlog, nearly $2.0 million in revenue, converts into recognized revenue once external funding is secured.
- MediBeacon converts its CE mark, FDA IDE approvals and China NMPA approval into commercial sales.
- The DBM Global sale does not close, leaving the parent's capital structure pressure unresolved against $699.0 million of principal debt and a going concern qualification.
- Customer concentration stays high: two unnamed Infrastructure customers were 31.0% and 13.9% of Q1 2026 revenue, and a loss or delay at either would cut into revenue.
- Steel-cost inflation keeps Infrastructure gross margin under pressure, with 67.2% of steel and steel component value purchased from two domestic vendors in FY2025.
- R2 fails to convert demand into revenue, or its external capital raise is highly dilutive, after a 48.4% revenue decline.
- Spectrum's advertising weakness continues with no disclosed recovery timeline, and carrier launch discussions do not become launches.
Looking Ahead
Over the next 12 months the company's shape depends on whether the DBM Global sale closes, how the proceeds are used, and whether R2 finds external capital. Management says Spectrum has completed carrier trials and that discussions are underway for new market launches in the second half of 2026. DBM Global said it had early success building backlog for 2027.
- H2 20265G broadcast launches — Carrier launch discussions follow completed trials.
- 2026R2 external capital raise — R2 is seeking funding to continue progress through the year.
- No date disclosedDBM Global sale closing — IES agreed to acquire DBM Global for about $650 million.
Financials
Annual Summary
| Metric | FY2024 | FY2025 | TTM | YoY |
|---|---|---|---|---|
| Revenue | $1.1B | $1.2B | $1.5B | +12.5% |
| Gross Margin | 19.0% | 15.3% | 15.1% | 370bps |
| EBITDA | $73M | $62M | $94M | -15.0% |
| EBITDA Margin | 6.6% | 5.0% | 6.2% | 161bps |
| Net Income | −$35M | −$61M | −$22M | -75.1% |
| Free Cash Flow | −$10M | $120M | $142M | — |
| Net Cash | — | — | — | — |
Key Ratios (Trailing)
- P/E TTM—
- EV/EBITDA TTM—
- EV/Revenue TTM—
- Price/FCF TTM—
- Gross Margin (TTM)15.1%
- EBITDA Margin (TTM)6.2%
- Net Margin (TTM)-1.5%
- ROIC14.9%
- FCF Conversion151.2%
- SBC / Revenue0.2%
The Company
INNOVATE Corp. is a diversified holding company whose operating results come almost entirely from one subsidiary, DBM Global. DBM Global is a fully integrated construction company that fabricates and erects structural steel through Schuff Steel Company, Banker Steel and GrayWolf Industrial. The AI-relevant part of that work is structural steel for data centers and chipmaker facilities, alongside services tied to AI infrastructure, energy systems, advanced manufacturing and digital connectivity. The other two segments are Life Sciences — R2 Technologies' Glacial skin devices, the MediBeacon TGFR kidney-function measurement system and Genovel's knee replacements — and Spectrum, which owns and operates broadcast television stations.
DBM Global runs its own fabrication footprint rather than outsourcing it. Schuff Steel operates six fabrication shops in Arizona, California, Kansas and Utah, which the 10-K describes as one of the highest fabrication capacities in the United States. Banker Steel operates three shops in New Jersey and Virginia with a disclosed maximum annual fabrication capacity of about 139,000 tons. DBM Global is headquartered in Phoenix, Arizona, and INNOVATE's corporate headquarters is in New York. R2 Technologies is based in Dublin, California, and relies on a single third-party contract manufacturer in Sunnyvale, California.
Business Segments
Competitive Landscape
The 10-K discusses competition mainly at the holding-company level: INNOVATE says it faces competition for acquisition and business opportunities from strategic investors and private equity firms. For the Infrastructure work itself, the source material identifies fabricators that customers could shift to if DBM Global could not deliver — SME Steel and W&W / AFCO Steel — plus a Nucor fabrication division and AISC member fabricators listed in the supply-chain dataset. A computed criticality read concludes that a failure of the Infrastructure segment would cause minor delays as customers move to other fabricators, with no systemic slowdown. The company's own filings do not name a fabricator competitor.
- SME Steel ContractorsNamed in the criticality assessment as a fabricator customers could shift to; not discussed in company filings.
- W&W / AFCO SteelNamed in the criticality assessment as a fabricator customers could shift to; not discussed in company filings.
- Nucor fabrication divisionListed as a fabricator competitor in the supply-chain wiring dataset; not confirmed in company filings.
- CMCCMC describes itself as positioning as a broader Construction Solutions provider; an inferred competitive read from CMC's own commentary.
Supply Chain
DBM Global sits downstream of steel producers and upstream of the general contractors and owners building data centers and advanced-manufacturing plants. No company in the supply-chain intelligence set mentions VATE, DBM Global, R2, MediBeacon or Spectrum by name.